| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.22692 |
| P8608 | Fatcat ID | release_774h66qajfgolpqpoe2ikjecg4 |
| P932 | PMC publication ID | 4143141 |
| P698 | PubMed publication ID | 24829092 |
| P5875 | ResearchGate publication ID | 262344091 |
| P50 | author | Amanda K Huber | Q57739213 |
| P2093 | author name string | David N Irani | |
| Emily K Rainey-Barger | |||
| Nilufer Esen | |||
| Pennelope K Blakely | |||
| P2860 | cites work | IRF7: activation, regulation, modification and function | Q24299740 |
| B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Regulation of Homeostatic Chemokine Expression and Cell Trafficking During Immune Responses | Q57227496 | ||
| Turning off follicular dendritic cells | Q59068710 | ||
| Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid | Q59543689 | ||
| Differential induction of chemokines in human microglia by type I and II interferons | Q73372530 | ||
| Recent advances in chemokines and chemokine receptors | Q78165392 | ||
| Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica | Q82254306 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis | Q27480965 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
| IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
| Regulation of learning and memory by meningeal immunity: a key role for IL-4 | Q30434189 | ||
| Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells | Q33500436 | ||
| Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
| The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). | Q33654152 | ||
| Lymphoid chemokines in the CNS. | Q34020894 | ||
| Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
| Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. | Q34191599 | ||
| Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen | Q34488105 | ||
| CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses | Q34726022 | ||
| The evolution of transthyretin synthesis in the choroid plexus | Q35054926 | ||
| The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
| Chemokines in the systemic organization of immunity | Q35216944 | ||
| The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity | Q35216957 | ||
| Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis | Q35861950 | ||
| Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza | Q35973395 | ||
| Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
| Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia | Q36647941 | ||
| BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma | Q36762885 | ||
| Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis | Q36943086 | ||
| Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. | Q37123896 | ||
| Lymphoid chemokines in chronic neuroinflammation | Q37186200 | ||
| Intrathecal humoral immunity to encephalitic RNA viruses. | Q38084075 | ||
| Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis | Q39552072 | ||
| Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. | Q39808939 | ||
| Novel lymphocyte-specific CC chemokines and their receptors. | Q41640121 | ||
| BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
| Central role of interferon-beta in thymic events leading to myasthenia gravis | Q42244993 | ||
| Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis | Q42840679 | ||
| Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
| Unique transcriptome signature of mouse microglia | Q44305324 | ||
| Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection | Q47603503 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Long term intraparenchymal Ig secretion after acute viral encephalitis in mice | Q48394895 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microglia | Q1622829 |
| P304 | page(s) | 1452-1462 | |
| P577 | publication date | 2014-05-14 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. | |
| P478 | volume | 62 |
| Q36646146 | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. |
| Q39148044 | Brain inflammation is accompanied by peripheral inflammation in Cstb (-/-) mice, a model for progressive myoclonus epilepsy. |
| Q40865607 | CD14 is a key organizer of microglial responses to CNS infection and injury |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q26778348 | Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues |
| Q26779177 | Hypersensitivity Responses in the Central Nervous System |
| Q89659517 | Impaired Innate Immunity Mechanisms in the Brain of Alzheimer's Disease |
| Q52145462 | Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury. |
| Q91474280 | Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress |
| Q38655679 | Oxidative stress in multiple sclerosis: Central and peripheral mode of action |
| Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
| Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
| Q47110972 | Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation. |
| Q36551188 | Targeting CXCL13 During Neuroinflammation |
Search more.